This Week in Nature | GenomeWeb

This Week in Nature

In Nature Biotechnology this week, a team of University of Tokyo researchers reports the development of a photoactivatable version of the genome-editing technology CRISPR/Cas9 that functions in human cells. They demonstrate how, in response to blue light irradiation, the modified CRISPR/Cas9 molecules could induce targeted genome sequence modifications through both non-homologous end joining and homology-directed repair pathways.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.